Sharda Cropchem Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
SHARDACROP · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Sharda Cropchem Limited reported strong full-year results for FY2025-26. Consolidated revenue grew 22% to Rs. 526,758 lakhs from Rs. 431,985 lakhs in the prior year. Net profit after tax more than doubled to Rs. 68,099 lakhs compared to Rs. 30,442 lakhs in FY25, representing a 124% increase. EPS (diluted) improved to Rs. 75.47 from Rs. 33.74. The board recommended a final dividend of Rs. 9 per equity share (face value Rs. 10). Segment-wise, agrochemicals revenue grew 25% to Rs. 471,686 lakhs while non-agrochemicals remained flat at Rs. 55,073 lakhs. Statutory auditors B S R & Co. LLP issued an unmodified (clean) audit opinion with no qualifications or reservations. The company has 39 subsidiaries across multiple countries.
The results reflect robust performance with double-digit revenue growth and exceptional profit expansion, driven primarily by the agrochemicals segment. The clean audit opinion and dividend payout signal financial stability, which should be positively viewed by shareholders.